Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Manniche

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Pharmacologica Et Toxicologica|September 1, 1984
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in manP Tfelt-Hansen, P M Manniche
Current Medical Research and Opinion|January 1, 1984
The pharmacokinetics of the individual constituents of an aspirin-metoclopramide combination ('Migravess')P M Manniche, L C Dinneen, M Langemark
Pharmacopsychiatry|September 1, 1988
Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind studyJ Suominen, T Tamminen, R Elosuo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1994
The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patientsJ Lundmark, J Wålinder, C Alling, et al.
Clinical Pharmacology and Therapeutics|June 4, 2010
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersK A Schoedel, D Meier, B Chakraborty, et al.
Acta Psychiatrica Scandinavica|September 1, 1991
Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurementsO A Nielsen, I Morsing, J S Petersen, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Paroxetine: pharmacokinetic and antidepressant effect in the elderlyJ Lundmark, I Scheel Thomsen, T Fjord-Larsen, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1995
Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled studyS Oehrberg, P E Christiansen, K Behnke, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Pharmacologica Et Toxicologica|September 1, 1984
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in manP Tfelt-Hansen, P M Manniche
Current Medical Research and Opinion|January 1, 1984
The pharmacokinetics of the individual constituents of an aspirin-metoclopramide combination ('Migravess')P M Manniche, L C Dinneen, M Langemark
Pharmacopsychiatry|September 1, 1988
Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind studyJ Suominen, T Tamminen, R Elosuo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1994
The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patientsJ Lundmark, J Wålinder, C Alling, et al.
Clinical Pharmacology and Therapeutics|June 4, 2010
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersK A Schoedel, D Meier, B Chakraborty, et al.
Acta Psychiatrica Scandinavica|September 1, 1991
Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurementsO A Nielsen, I Morsing, J S Petersen, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Paroxetine: pharmacokinetic and antidepressant effect in the elderlyJ Lundmark, I Scheel Thomsen, T Fjord-Larsen, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1995
Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled studyS Oehrberg, P E Christiansen, K Behnke, et al.
Pageof 1